The immunity-related discrepancies consisted of augmented proportions of monocytes and classical monocytes in MS, in contrast to the higher proportions of DCs, myeloid dendritic cells (mDCs), and CD28+ T cells in NC. This evidence concerns the gene CD28 and myeloid sarcoma.